NCT03333395View on ClinicalTrials.gov

Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPD

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Mechanically Ventilated Patients
Interventions
DRUG

Nebulized heparin and salbutamol

HS Group medications (study group) (30 patients) which was prepared by adding Heparin 25000 IU in 5ml (5 ampoules of Heparin Sodium 5000 I.U/ML, Nile company for Pharmaceuticals and Chemical Industries-A.R.E.) to Salbutamol 5mg/2.5ml Nebulizer Solution (one Ventolin nebule containing a preservative-free solution of Salbutamol Sulphate BP 2.5mg, GlaxoSmithKline Inc.)

DRUG

Nebulized salbutamol

S Group medications (control group) (30 patients) which was prepared by adding Salbutamol 5mg/2.5ml Nebulizer Solution + Na cl 0.9% 5ml.

Trial Locations (1)

Unknown

Internal Medicine ICU of Ain-Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03333395 - Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPD | Biotech Hunter | Biotech Hunter